Çuhadar Serap, Köseoğlu Mehmet, Çinpolat Yasemin, Buğdaycı Güler, Usta Murat, Semerci Tuna
Katip Celebi University, Ataturk Training and Research Hospital, Department of Clinical Biochemistry, Izmir, Turkey.
Abant İzzet Baysal University, Department of Clinical Biochemistry, Bolu, Turkey.
Biochem Med (Zagreb). 2016;26(1):53-60. doi: 10.11613/BM.2016.004.
Extremely high glucose concentrations have been shown to interfere with creatinine assays especially with Jaffe method in peritoneal dialysate. Because diabetes is the fastest growing chronic disease in the world, laboratories study with varying glucose concentrations. We investigated whether different levels of glucose spiked in serum interfere with 21 routine chemistry and thyroid assays at glucose concentrations between 17-51 mmol/L.
Baseline (group I) serum pool with glucose concentration of 5.55 (5.44-5.61) mmol/L was prepared from patient sera. Spiking with 20% dextrose solution, sample groups were obtained with glucose concentrations: 17.09, 34.52, and 50.95 mmol/L (group II, III, IV, respectively). Total of 21 biochemistry analytes and thyroid tests were studied on Abbott c8000 and i2000sr with commercial reagents. Bias from baseline value was checked statistically and clinically.
Creatinine increased significantly by 8.74%, 31.66%, 55.31% at groups II, III, IV, respectively with P values of < 0.001. At the median glucose concentration of 50.95 mmol/L, calcium, albumin, chloride and FT4 biased significantly clinically (-0.85%, 1.63%, 0.65%, 7.4% with P values 0.138, 0.214, 0.004, < 0.001, respectively). Remaining assays were free of interference.
Among the numerous biochemical parameters studied, only a few parameters are affected by dramatically increased glucose concentration. The creatinine measurements obtained in human sera with the Jaffe alkaline method at high glucose concentrations should be interpreted with caution. Other tests that were affected with extremely high glucose concentrations were calcium, albumin, chloride and FT4, hence results should be taken into consideration in patients with poor diabetic control.
已表明极高的葡萄糖浓度会干扰肌酐检测,尤其是在腹膜透析液中采用Jaffe法时。由于糖尿病是全球增长最快的慢性病,实验室对不同葡萄糖浓度进行了研究。我们调查了血清中添加不同水平的葡萄糖(浓度在17 - 51 mmol/L之间)是否会干扰21项常规化学和甲状腺检测。
从患者血清中制备葡萄糖浓度为5.55(5.44 - 5.61)mmol/L的基线(I组)血清池。用20%葡萄糖溶液加样,获得葡萄糖浓度分别为17.09、34.52和50.95 mmol/L的样本组(分别为II组、III组、IV组)。使用商业试剂在雅培c8000和i2000sr上对总共21种生化分析物和甲状腺检测项目进行研究。从统计学和临床角度检查与基线值的偏差。
II组、III组、IV组的肌酐分别显著增加了8.74%、31.66%、55.31%,P值均<0.001。在葡萄糖浓度中位数为50.95 mmol/L时,钙、白蛋白、氯和游离甲状腺素(FT4)在临床上有显著偏差(分别为-0.85%、1.63%、0.65%、7.4%,P值分别为0.138、0.214、0.004、<0.001)。其余检测不受干扰。
在研究的众多生化参数中,只有少数参数会受到显著升高的葡萄糖浓度的影响。在高葡萄糖浓度下采用Jaffe碱性法在人血清中测得的肌酐值应谨慎解读。受极高葡萄糖浓度影响的其他检测项目是钙、白蛋白、氯和FT4,因此对于糖尿病控制不佳的患者,应考虑这些结果。